Hudson Bay Capital Management
ACER

Hudson Bay Capital Management’s Acer Therapeutics Inc ACER Stock Holding History

Hudson Bay Capital Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-274,300
Closed -$253K – 1033
2023
Q2 		$253K Buy
+274,300
New +$243K ﹤0.01% 653
2015
Q2 		– Sell
-5,400
Closed -$275K – 264
2015
Q1 		$275K Buy
+5,400
New +$331K 0.01% 163

Other funds holding ACER

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Hudson Bay Capital Management's ACER Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 274,300 shares — an estimated $253K sold.

Hudson Bay Capital Management first reported a position in ACER in Q1 2015 and held it in 2 quarters. The position peaked at $275K in Q1 2015. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Hudson Bay Capital Management reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 274,300 Acer Therapeutics Inc shares in Q3 2023, an estimated $253K.
  • Hudson Bay Capital Management first reported a position in Acer Therapeutics Inc in Q1 2015 and held it in 2 quarters.
  • Hudson Bay Capital Management's Acer Therapeutics Inc position peaked at $275K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.